Relevant and even prescient commentary on news, politics and the economy.

Pharmacy Benefit Managers (PBMs) are Hiking the Price of Drugs

A follow-up to the much longer report on Insulin (test on this later) and how PBMs impact pricing on other drugs. “Insulin A Drug Pricing Analysis,” Angry Bear. “Drug manufacturers alone set and raise drug prices, and PBMs are holding drug companies accountable by negotiating the lowest possible cost for drugs, including insulins, on behalf […]

Buprenorphine IV: What about Cocaine and Methamphetamine?

I have been thinking about buprenorphine, naltrexone and the stimulants cocaine and methamphetamine. An issue which came to my mind recently and which I think it worth discussing is that cocaine is often cut and replaced with fentanyl to hide the over-dilution. This is sometimes done sloppily leading to fentanyl overdoses of people who did […]

Public funding for bringing transformative drugs to market

AB: It is a government policy to turn the fruits of its research over to private industry without any strings attached. The 1980 Bayh-Dole Act allows the National Institutes of Health (NIH) and universities housing government-funded scientists to patent and transfer (for royalties, of course) their scientific discoveries, research tools, and drug candidates to private […]

Homicides Over Time, Plus a Question About Drugs

I was looking for information on drug related murders and inadvertently stumbled on this old Bureau of Justice of Statistics report. There’s a lot of interesting information in it. One fascinating table is this: For context, here is the population breakdown over a period that includes the timespan in the table. I’m not sure this […]